Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 7 Neoplasms 3 Melanoma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Obesity 2 Infertility 2 Glioblastoma 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 TP53 Y220C Mutation 1 Sarcoma, Ewing 1 Sarcoma 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Posterior Fossa Ependymal Tumor 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms by Site 1 Metabolic Diseases 1 Medulloblastoma 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

Spironolactone 2 Progesterone 2 Physical Examination 1 Metformin 1 Magnesium 1 Carnitine 1 Blood Pressure Monitoring, Ambulatory 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperandrogenism × Metformin × Clear all

NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡